Genmab Announces Interim Results of Ofatumumab Phase II Stud

Kesimpta is a subcutaneously injected anti CD20 monoclonal antibody approved for RRMS and active progressive MS.
Post Reply
User avatar
scorpion
Family Elder
Posts: 1323
Joined: Wed Nov 05, 2008 3:00 pm

Genmab Announces Interim Results of Ofatumumab Phase II Stud

Post by scorpion » Tue Jul 06, 2010 11:50 am


Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Kesimpta (Ofatumumab)”